Risk factor
Poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Expleo Solutions Limited, together with its subsidiaries, primarily provides software validation and verification services to the banking, financial services, and insurance industries worldwide. It offers quality engineering, quality management, software testing, DevOps, and test automation services. The company was formerly known as SQS India BFSI Limited and changed its name to Expleo Solutions Limited in April 2019. Expleo Solutions Limited was incorporated in 1998 and is based in Chennai, India. Expleo Solutions Limited Limited is a subsidiary of Expleo Technology Germany GmbH.
Company Valuation
Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E, 'cheap' on EV/EBIT
Target Price
The average target price of EXPLEOSOL.NS is 1353 and suggests 81% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation t
Buy
Sell